BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paradis V, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, Belghiti J, Bedossa P. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology. 2007;46:140-146. [PMID: 17596890 DOI: 10.1002/hep.21684] [Cited by in Crossref: 123] [Cited by in F6Publishing: 98] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Marín Camero N, Fernández Aguilar JL, Sánchez Pérez B, Suárez Muñoz MÁ, Santoyo Santoyo J. De la hiperplasia nodular focal al adenoma inflamatorio hepático. Cirugía Española 2012;90:200-1. [DOI: 10.1016/j.ciresp.2010.12.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Nomura Y, Nakashima O, Kumabe T, Akiba J, Ogasawara S, Kage M, Kinoshita H, Yano H. Clinicopathologic analysis of the simple nodular type of well-differentiated hepatocellular carcinoma with extensive peliotic change. J Gastroenterol Hepatol 2014;29:1494-99. [PMID: 25587618 DOI: 10.1111/jgh.12565] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Bioulac-sage P, Balabaud C, Zucman-rossi J. Les tumeurs hépatocytaires bénignes – des connaissances récentes : de la biologie moléculaire au diagnostic. Gastroentérologie Clinique et Biologique 2008;32:296-303. [DOI: 10.1016/j.gcb.2008.02.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Bellamy COC, Maxwell RS, Prost S, Azodo IA, Powell JJ, Manning JR. The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre: Hepatocellular adenomas. Histopathology 2013;62:431-45. [DOI: 10.1111/his.12011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
5 Katabathina VS, Menias CO, Shanbhogue AK, Jagirdar J, Paspulati RM, Prasad SR. Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics. 2011;31:1529-1543. [PMID: 21997980 DOI: 10.1148/rg.316115527] [Cited by in Crossref: 106] [Cited by in F6Publishing: 77] [Article Influence: 10.6] [Reference Citation Analysis]
6 Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int. 2012;32:1217-1221. [PMID: 22429502 DOI: 10.1111/j.1478-3231.2012.02786.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 71] [Article Influence: 8.6] [Reference Citation Analysis]
7 Kumagawa M, Matsumoto N, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Ogawa M, Matsuoka S, Moriyama M, Takayama T, Sugitani M. Contrast-enhanced ultrasonographic findings of serum amyloid A-positive hepatocellular neoplasm: Does hepatocellular adenoma arise in cirrhotic liver? World J Hepatol 2016; 8(26): 1110-1115 [PMID: 27660679 DOI: 10.4254/wjh.v8.i26.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Furlan A, van der Windt DJ, Nalesnik MA, Sholosh B, Ngan K, Pealer KM, Ijzermans JNM, Federle MP. Multiple Hepatic Adenomas Associated with Liver Steatosis at CT and MRI: A Case-Control Study. American Journal of Roentgenology 2008;191:1430-5. [DOI: 10.2214/ajr.07.3419] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
9 Sempoux C, Balabaud C, Bioulac-Sage P. Malignant transformation of hepatocellular adenoma. Hepat Oncol. 2014;1:421-431. [PMID: 30190977 DOI: 10.2217/hep.14.14] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
10 Di Pietropaolo M, Briani C, Pilozzi E, Carbonetti F, David V, Iannicelli E. Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature. J Gastrointest Cancer 2015;46:421-5. [PMID: 25894634 DOI: 10.1007/s12029-015-9715-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Dokmak S, Belghiti J. Will weight loss become a future treatment of hepatocellular adenoma in obese patients? Liver Int. 2015;35:2228-2232. [PMID: 26216699 DOI: 10.1111/liv.12925] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
12 Ronot M, Paradis V, Duran R, Kerbaol A, Vullierme MP, Belghiti J, Valla DC, Vilgrain V. MR findings of steatotic focal nodular hyperplasia and comparison with other fatty tumours. Eur Radiol. 2013;23:914-923. [PMID: 23064717 DOI: 10.1007/s00330-012-2676-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
13 Takayassu TC, Marchiori E, Eiras A, Cabral RF, Cabral FC, Batista RR, Zanetti G, Dias PC. Telangiectatic adenoma - computed tomography and magnetic resonance findings: a case report and review of the literature. Cases J 2009;2:24. [PMID: 19128493 DOI: 10.1186/1757-1626-2-24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Zech CJ, Bartolozzi C, Bioulac-sage P, Chow PK, Forner A, Grazioli L, Huppertz A, Laumonier H, Min Lee J, Murakami T, Ricke J, Sirlin CB. Consensus Report of the Fifth International Forum for Liver MRI. American Journal of Roentgenology 2013;201:97-107. [DOI: 10.2214/ajr.12.9491] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
15 Dardenne S, Hubert C, Sempoux C, Annet L, Jouret-Mourin A, Horsmans Y, Van Beers BE, Zech F, Gigot JF. Conservative and operative management of benign solid hepatic tumours: a successful stratified algorithm. Eur J Gastroenterol Hepatol. 2010;22:1337-1344. [PMID: 20683192 DOI: 10.1097/MEG.0b013e32833db907] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
16 Shafizadeh N, Genrich G, Ferrell L, Kakar S. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up. Human Pathology 2014;45:976-83. [DOI: 10.1016/j.humpath.2013.12.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
17 Marzano C, Cazals-Hatem D, Rautou PE, Valla DC. The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome. Hepatology. 2015;62:956-963. [PMID: 25684451 DOI: 10.1002/hep.27747] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
18 Paradis V. Histopathology of hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:21-32. [PMID: 22941011 DOI: 10.1007/978-3-642-16037-0_2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
19 Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, Vilgrain V, Paradis V. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology. 2011;53:1182-1191. [PMID: 21480324 DOI: 10.1002/hep.24147] [Cited by in Crossref: 148] [Cited by in F6Publishing: 124] [Article Influence: 13.5] [Reference Citation Analysis]
20 Paradis V. Hepatocellular Adenomas. Surgical Pathology Clinics 2013;6:311-31. [DOI: 10.1016/j.path.2013.03.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Bioulac-sage P, Balabaud C, Zucman-rossi J. Apport de l’immunohistochimie dans le diagnostic des tumeurs hépatocellulaires bénignes. Annales de Pathologie 2010;30:439-47. [DOI: 10.1016/j.annpat.2010.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Clément B, Chêne G, Degos F. A national collection of liver tumours: Lessons learnt from 6 years of biobanking in France. Cancer Letters 2009;286:140-4. [DOI: 10.1016/j.canlet.2009.04.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
23 Cherqui D. [Clinical management of benign liver cell tumors]. Gastroenterol Clin Biol 2008;32:310-3; quiz 293, 314. [PMID: 18359592 DOI: 10.1016/j.gcb.2008.02.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
24 Landi F, De' Angelis N, Scatton O, Vidal X, Ayav A, Muscari F, Dokmak S, Torzilli G, Demartines N, Soubrane O, Cherqui D, Hardwigsen J, Laurent A. Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group. Surg Endosc 2017;31:4136-44. [PMID: 28281121 DOI: 10.1007/s00464-017-5466-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
25 Dokmak S, Cauchy F, Belghiti J. Resection, transplantation and local regional therapies for liver adenomas. Expert Rev Gastroenterol Hepatol 2014;8:803-10. [PMID: 24957321 DOI: 10.1586/17474124.2014.917957] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
26 Klompenhouwer AJ, de Man RA, Dioguardi Burgio M, Vilgrain V, Zucman-Rossi J, Ijzermans JNM. New insights in the management of Hepatocellular Adenoma. Liver Int 2020;40:1529-37. [PMID: 32464711 DOI: 10.1111/liv.14547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65:386-398. [PMID: 27085809 DOI: 10.1016/j.jhep.2016.04.001] [Cited by in Crossref: 201] [Cited by in F6Publishing: 153] [Article Influence: 33.5] [Reference Citation Analysis]
28 Marrero JA, Ahn J, Rajender Reddy K; Americal College of Gastroenterology. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol 2014;109:1328-47; quiz 1348. [PMID: 25135008 DOI: 10.1038/ajg.2014.213] [Cited by in Crossref: 184] [Cited by in F6Publishing: 133] [Article Influence: 23.0] [Reference Citation Analysis]
29 Agrawal S, Agarwal S, Arnason T, Saini S, Belghiti J. Management of Hepatocellular Adenoma: Recent Advances. Clin Gastroenterol Hepatol. 2015;13:1221-1230. [PMID: 24909909 DOI: 10.1016/j.cgh.2014.05.023] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
30 Huang WC, Liau JY, Jeng YM, Liu KL, Lin CN, Song HL, Tsai JH. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype. J Gastroenterol Hepatol 2020;35:680-8. [PMID: 31698521 DOI: 10.1111/jgh.14903] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
31 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. Characterization of hepatocellular adenoma based on the phenotypic classification: The Kanazawa experience. Hepatol Res. 2011;41:982-988. [PMID: 21883740 DOI: 10.1111/j.1872-034x.2011.00851.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 3.9] [Reference Citation Analysis]
32 Pratt DS. Liver disorders. Curr Opin Gastroenterol 2008;24:265-8. [PMID: 18408453 DOI: 10.1097/MOG.0b013e3282fbd371] [Reference Citation Analysis]
33 Paradis V. Benign Liver Tumors: An update. Clinics in Liver Disease 2010;14:719-29. [DOI: 10.1016/j.cld.2010.07.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
34 Lefkowitch JH. Hepatobiliary pathology. Curr Opin Gastroenterol 2008;24:269-77. [PMID: 18408454 DOI: 10.1097/MOG.0b013e3282f8e28f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Vinciguerra M, Carrozzino F, Peyrou M, Carlone S, Montesano R, Benelli R, Foti M. Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol. 2009;50:1132-1141. [PMID: 19398230 DOI: 10.1016/j.jhep.2009.01.027] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
36 Nault JC, Zucman Rossi J. Molecular classification of hepatocellular adenomas. Int J Hepatol. 2013;2013:315947. [PMID: 23401783 DOI: 10.1155/2013/315947] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
37 Laumonier H, Rullier A, Saric J, Balabaud C, Bioulac-Sage P. Unexpected discovery of 2 cases of hepatocyte nuclear factor 1α-mutated infracentimetric adenomatosis. World J Gastroenterol 2008; 14(30): 4830-4833 [PMID: 18720549 DOI: 10.3748/wjg.14.4830] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology. 2012;262:511-519. [PMID: 22143926 DOI: 10.1148/radiol.11110922] [Cited by in Crossref: 63] [Cited by in F6Publishing: 48] [Article Influence: 5.7] [Reference Citation Analysis]
39 Nahon P, Allaire M, Nault JC, Paradis V. Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinoma. Hepat Oncol 2020;7:HEP36. [PMID: 33680428 DOI: 10.2217/hep-2020-0017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Kai K, Miyoshi A, Tokunaga O, Kitahara K, Takahashi T, Miyake S, Egashira Y, Irie H, Noshiro H, Miyazaki K. A hepatocellular neoplasm accompanied with massive histiocyte infiltration. Clin J Gastroenterol 2010;3:40-4. [DOI: 10.1007/s12328-009-0123-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Han J, van den Heuvel MC, Kusano H, de Jong KP, Gouw AS. How normal is the liver in which the inflammatory type hepatocellular adenoma develops? Int J Hepatol 2012;2012:805621. [PMID: 23024866 DOI: 10.1155/2012/805621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
42 Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology. 2013;144:888-902. [PMID: 23485860 DOI: 10.1053/j.gastro.2013.02.032] [Cited by in Crossref: 199] [Cited by in F6Publishing: 145] [Article Influence: 22.1] [Reference Citation Analysis]
43 Maylee H, Harada K, Igarashi S, Tohda G, Yamamoto M, Ren XS, Osawa T, Hasegawa Y, Takahashi N, Nakanuma Y. Case of telangiectatic/inflammatory hepatocellular adenoma arising in a patient with primary sclerosing cholangitis. Hepatol Res. 2012;42:611-618. [PMID: 22568458 DOI: 10.1111/j.1872-034X.2011.00962.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Agarwal S, Fuentes-Orrego JM, Arnason T, Misdraji J, Jhaveri KS, Harisinghani M, Hahn PF. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. AJR Am J Roentgenol. 2014;203:W408-W414. [PMID: 25055198 DOI: 10.2214/ajr.13.12251] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 6.1] [Reference Citation Analysis]
45 Sasaki M, Yoneda N, Kitamura S, Sato Y, Nakanuma Y. A serum amyloid A-positive hepatocellular neoplasm arising in alcoholic cirrhosis: a previously unrecognized type of inflammatory hepatocellular tumor. Mod Pathol. 2012;25:1584-1593. [PMID: 22766792 DOI: 10.1038/modpathol.2012.114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
46 van Aalten SM, Verheij J, Terkivatan T, Dwarkasing RS, de Man RA, Ijzermans JN. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. J Hepatol. 2011;55:120-125. [PMID: 21145863 DOI: 10.1016/j.jhep.2010.10.030] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
47 Ronot M, Vilgrain V. Imaging of benign hepatocellular lesions: current concepts and recent updates. Clin Res Hepatol Gastroenterol. 2014;38:681-688. [PMID: 24636468 DOI: 10.1016/j.clinre.2014.01.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
48 Tobari M, Hashimoto E, Taniai M, Nishino T, Tokushige K. Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease. Clin J Gastroenterol 2020;13:1289-96. [PMID: 32880022 DOI: 10.1007/s12328-020-01215-3] [Reference Citation Analysis]
49 Shanbhogue A, Shah SN, Zaheer A, Prasad SR, Takahashi N, Vikram R. Hepatocellular adenomas: current update on genetics, taxonomy, and management. J Comput Assist Tomogr. 2011;35:159-166. [PMID: 21412084 DOI: 10.1097/RCT.0b013e31820bad61] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
50 Goodman ZD. The Impact of Obesity on Liver Histology. Clinics in Liver Disease 2014;18:33-40. [DOI: 10.1016/j.cld.2013.09.010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
51 Thomeer MG, Broker M, Verheij J, Doukas M, Terkivatan T, Bijdevaate D, De Man RA, Moelker A, IJzermans JN. Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol. 2016;9:898-912. [PMID: 27803743 DOI: 10.1177/1756283x16663882] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.8] [Reference Citation Analysis]
52 Vinciguerra M, Foti M. PTEN at the crossroad of metabolic diseases and cancer in the liver. Annals of Hepatology 2008;7:192-9. [DOI: 10.1016/s1665-2681(19)31848-4] [Cited by in Crossref: 38] [Article Influence: 2.7] [Reference Citation Analysis]
53 Bioulac-Sage P, Sempoux C, Possenti L, Frulio N, Laumonier H, Laurent C, Chiche L, Frédéric Blanc J, Saric J, Trillaud H, Le Bail B, Balabaud C. Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context. Int J Hepatol 2013;2013:253261. [PMID: 23691330 DOI: 10.1155/2013/253261] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
54 Castain C, Sempoux C, Brunt EM, Causse O, Heitzmann A, Hernandez-prera JC, Le Bail B, Schirmacher P, Thung SN, Balabaud C, Bioulac-sage P. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association? Histopathology 2014;64:890-5. [DOI: 10.1111/his.12326] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
55 Kato K, Abe H, Hanawa N, Fukuzawa J, Matsuo R, Yonezawa T, Itoh S, Sato Y, Ika M, Shimizu S, Endo S, Hano H, Izu A, Sugitani M, Tsubota A. Hepatocellular adenoma in a woman who was undergoing testosterone treatment for gender identity disorder. Clin J Gastroenterol. 2018;11:401-410. [PMID: 29589251 DOI: 10.1007/s12328-018-0854-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
56 Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11:737-749. [PMID: 25178878 DOI: 10.1038/nrgastro.2014.151] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
57 Manichon AF, Bancel B, Durieux-Millon M, Ducerf C, Mabrut JY, Lepogam MA, Rode A. Hepatocellular adenoma: evaluation with contrast-enhanced ultrasound and MRI and correlation with pathologic and phenotypic classification in 26 lesions. HPB Surg 2012;2012:418745. [PMID: 22811588 DOI: 10.1155/2012/418745] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
58 Bunchorntavakul C, Bahirwani R, Drazek D, Soulen MC, Siegelman ES, Furth EE, Olthoff K, Shaked A, Reddy KR. Clinical features and natural history of hepatocellular adenomas: the impact of obesity: Hepatocellular adenomas and obesity. Alimentary Pharmacology & Therapeutics 2011;34:664-74. [DOI: 10.1111/j.1365-2036.2011.04772.x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
59 Larson BK, Guindi M. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice. Am J Clin Pathol 2017;147:557-70. [PMID: 28472207 DOI: 10.1093/ajcp/aqx010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
60 Krause K, Tanabe KK. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Ann Surg Oncol 2020;27:3330-8. [PMID: 32542565 DOI: 10.1245/s10434-020-08580-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
61 Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009;49:851-859. [PMID: 19115377 DOI: 10.1002/hep.22734] [Cited by in Crossref: 377] [Cited by in F6Publishing: 341] [Article Influence: 29.0] [Reference Citation Analysis]
62 Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013;2013:604860. [PMID: 23509632 DOI: 10.1155/2013/604860] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 6.2] [Reference Citation Analysis]
63 Goodman ZD, Terracciano LM, Wee A. Tumours and tumour-like lesions of the liver. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 761-851. [DOI: 10.1016/b978-0-7020-3398-8.00014-3] [Cited by in Crossref: 21] [Article Influence: 2.1] [Reference Citation Analysis]
64 Hager T, Klein-Franke A, Jaschke W, Zelger B, Hager J. [Focal nodular hyperplasia in a 12-year-old boy: case report and considerations]. Pathologe 2012;33:254-61. [PMID: 22383052 DOI: 10.1007/s00292-012-1567-y] [Reference Citation Analysis]
65 Khaoudy I, Rebibo L, Regimbeau J. Is bariatric surgery a potential new treatment for large inflammatory hepatocellular adenomas in obese patients? Surgery for Obesity and Related Diseases 2018;14:535-8. [DOI: 10.1016/j.soard.2018.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
66 Ronot M, Kerbaol A, Rautou P, Brancatelli G, Bedossa P, Cazals-hatem D, Valla D, Vilgrain V. Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver. Eur Radiol 2016;26:3094-101. [DOI: 10.1007/s00330-015-4124-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.1] [Reference Citation Analysis]
67 Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-paul M, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-sage P, Zucman-rossi J. Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Mod Pathol 2016;29:43-50. [DOI: 10.1038/modpathol.2015.119] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
68 Bröker ME, Gaspersz MP, Klompenhouwer AJ, Hansen BE, Terkivatan T, Taimr P, Dwarkasing R, Thomeer MG, de Man RA, Ijzermans JN. Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI: . European Journal of Gastroenterology & Hepatology 2017;29:1183-8. [DOI: 10.1097/meg.0000000000000930] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
69 Oudmaijer CAJ, Berk KA, van der Louw EJTM, de Man R, van der Lelij AJ, Hoeijmakers JHJ, IJzermans J. KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study. BMJ Open 2022;12:e053559. [PMID: 35168973 DOI: 10.1136/bmjopen-2021-053559] [Reference Citation Analysis]
70 Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol. 2017;67:1074-1083. [PMID: 28733222 DOI: 10.1016/j.jhep.2017.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 14.2] [Reference Citation Analysis]
71 Torbenson M. Hepatic Adenomas. Surgical Pathology Clinics 2018;11:351-66. [DOI: 10.1016/j.path.2018.02.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
72 Soussan M, Aubé C, Bahrami S, Boursier J, Valla DC, Vilgrain V. Incidental focal solid liver lesions: diagnostic performance of contrast-enhanced ultrasound and MR imaging. Eur Radiol. 2010;20:1715-1725. [PMID: 20069427 DOI: 10.1007/s00330-009-1700-3] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
73 van Aalten SM, Witjes CD, de Man RA, Ijzermans JN, Terkivatan T. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int. 2012;32:28-37. [PMID: 22098685 DOI: 10.1111/j.1478-3231.2011.02667.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
74 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular Adenomas: Morphology and Genomics. Gastroenterol Clin North Am 2017;46:253-72. [PMID: 28506364 DOI: 10.1016/j.gtc.2017.01.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
75 Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology. 2009;137:1698-1705. [PMID: 19664629 DOI: 10.1053/j.gastro.2009.07.061] [Cited by in Crossref: 266] [Cited by in F6Publishing: 199] [Article Influence: 20.5] [Reference Citation Analysis]
76 Bayard Q, Caruso S, Couchy G, Rebouissou S, Bioulac Sage P, Balabaud C, Paradis V, Sturm N, de Muret A, Guettier C, Bonsang B, Copie C, Letouzé E, Calderaro J, Imbeaud S, Nault JC, Zucman-Rossi J. Recurrent chromosomal rearrangements of ROS1, FRK and IL6 activating JAK/STAT pathway in inflammatory hepatocellular adenomas. Gut 2020;69:1667-76. [PMID: 31907296 DOI: 10.1136/gutjnl-2019-319790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
77 Pérez Rojas J, Guarín Corredor MJ, Artes Martinez MJ, Vera Sempere FJ, Brisa Estelles C, Huart Peris MC, Hernandez Giron S. [Immunophenotypic classification of 3 cases of hepatocellular adenoma. Differential diagnosis with focal nodular hyperplasia]. Gastroenterol Hepatol 2013;36:388-95. [PMID: 23664829 DOI: 10.1016/j.gastrohep.2013.02.013] [Reference Citation Analysis]
78 Zulfiqar M, Sirlin CB, Yoneda N, Ronot M, Hecht EM, Chernyak V, Matsui O, Bastati N, Ba‐ssalamah A, Chatterjee D, Bashir M, Fowler KJ. Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach. J Magn Reson Imaging 2020;51:1630-40. [DOI: 10.1002/jmri.26902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
79 Bastati-Huber N, Pötter-Lang S, Ba-Ssalamah A. [Focal nodular hyperplasia and hepatocellular adenoma]. Radiologe 2015;55:18-26. [PMID: 25575723 DOI: 10.1007/s00117-014-2704-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Shaked O, Siegelman ES, Olthoff K, Reddy KR. Biologic and Clinical Features of Benign Solid and Cystic Lesions of the Liver. Clinical Gastroenterology and Hepatology 2011;9:547-562.e4. [DOI: 10.1016/j.cgh.2011.03.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
81 Bioulac-sage P, Cubel G, Balabaud C. Pathological diagnosis of hepatocellular adenoma in clinical practice. Diagnostic Histopathology 2011;17:521-9. [DOI: 10.1016/j.mpdhp.2011.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
82 Ba-Ssalamah A, Antunes C, Feier D, Bastati N, Hodge JC, Stift J, Cipriano MA, Wrba F, Trauner M, Herold CJ, Caseiro-Alves F. Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. Radiology. 2015;277:104-113. [PMID: 25985059 DOI: 10.1148/radiol.2015142366] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 9.6] [Reference Citation Analysis]
83 McInnes MD, Hibbert RM, Inácio JR, Schieda N. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review. Radiology 2015;277:413-23. [PMID: 26020440 DOI: 10.1148/radiol.2015142986] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
84 Ferrell LD, Kakar S, Terracciano LM, Wee A. Tumours and Tumour-like Lesions of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 780-879. [DOI: 10.1016/b978-0-7020-6697-9.00013-3] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
85 Bioulac-Sage P, Taouji S, Le Bail B, Possenti L, Balabaud C. Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens. Int J Hepatol. 2013;2013:417323. [PMID: 23509631 DOI: 10.1155/2013/417323] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
86 Venkatesh SK, Chandan V, Roberts LR. Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol. 2014;12:1414-1429. [PMID: 24055987 DOI: 10.1016/j.cgh.2013.09.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
87 Kamaya A, Maturen KE, Tye GA, Liu YI, Parti NN, Desser TS. Hypervascular Liver Lesions. Seminars in Ultrasound, CT and MRI 2009;30:387-407. [DOI: 10.1053/j.sult.2009.06.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
88 Taniai M, Hashimoto E, Tobari M, Kodama K, Tokushige K, Yamamoto M, Takayama T, Sugitani M, Sano K, Kondo F, Fukusato T. Clinicopathological investigation of steatohepatitic hepatocellular carcinoma: A multicenter study using immunohistochemical analysis of adenoma-related markers. Hepatol Res. 2018;48:947-955. [PMID: 30058778 DOI: 10.1111/hepr.13203] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
89 Oliveira S, Samba AK, Towbin AJ, Gupta A, Geller JI, Nathan JD, Kohli R. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH. Pediatr Obes 2018;13:70-3. [PMID: 27780309 DOI: 10.1111/ijpo.12189] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
90 Bioulac-Sage P, Laumonier H, Cubel G, Rossi JZ, Balabaud C. Hepatic resection for inflammatory hepatocellular adenomas: pathological identification of micronodules expressing inflammatory proteins. Liver Int. 2010;30:149-154. [PMID: 19845852 DOI: 10.1111/j.1478-3231.2009.02098.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
91 Dharmana H, Saravana-bawan S, Girgis S, Low G. Hepatocellular adenoma: imaging review of the various molecular subtypes. Clinical Radiology 2017;72:276-85. [DOI: 10.1016/j.crad.2016.12.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
92 Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Focal nodular hyperplasia, hepatocellular adenomas: past, present, future. Gastroenterol Clin Biol. 2010;34:355-358. [PMID: 20537479 DOI: 10.1016/j.gcb.2010.03.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
93 Thomeer MG, Willemssen FE, Biermann KK, El Addouli H, de Man RA, Ijzermans JN, Dwarkasing RS. MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents: Hepatobiliary MRI for Inflammatory Adenoma. J Magn Reson Imaging 2014;39:1259-64. [DOI: 10.1002/jmri.24281] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
94 Bioulac-Sage P, Laumonier H, Laurent C, Zucman-Rossi J, Balabaud C. Hepatocellular adenoma: what is new in 2008. Hepatol Int. 2008;2:316-321. [PMID: 19669260 DOI: 10.1007/s12072-008-9075-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
95 Bioulac-Sage P, Sempoux C, Balabaud C. Hepatocellular adenoma: Classification, variants and clinical relevance. Semin Diagn Pathol. 2017;34:112-125. [PMID: 28131467 DOI: 10.1053/j.semdp.2016.12.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
96 Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management. Clin Liver Dis 2020;24:389-403. [PMID: 32620279 DOI: 10.1016/j.cld.2020.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
97 Grazioli L, Olivetti L, Mazza G, Bondioni MP. MR Imaging of Hepatocellular Adenomas and Differential Diagnosis Dilemma. Int J Hepatol 2013;2013:374170. [PMID: 23606972 DOI: 10.1155/2013/374170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
98 Balabaud C, Al-Rabih WR, Chen PJ, Evason K, Ferrell L, Hernandez-Prera JC, Huang SF, Longerich T, Park YN, Quaglia A. Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification. Int J Hepatol. 2013;2013:268625. [PMID: 23691331 DOI: 10.1155/2013/268625] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
99 Larson BK, Guindi M. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas. Ann Diagn Pathol 2021;55:151833. [PMID: 34597957 DOI: 10.1016/j.anndiagpath.2021.151833] [Reference Citation Analysis]
100 Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5:HEP04. [PMID: 30302195 DOI: 10.2217/hep-2017-0023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
101 Agostini-vulaj D, Sharma AK, Findeis-hosey JJ, Mcmahon LA, Gonzalez RS. Distinction between inflammatory hepatocellular adenoma and mass effect on liver sampling. Human Pathology 2017;61:105-10. [DOI: 10.1016/j.humpath.2016.12.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]